— Know what they know.
Not Investment Advice
Also trades as: IMCC.CN (CNQ) · $vol 0M

IMCC NASDAQ

IM Cannabis Corp.
1W: -28.2% 1M: -32.0% 3M: -55.8% YTD: -95.4% 1Y: -96.4% 3Y: -98.2% 5Y: -100.0%
$2.04
-0.13 (-5.99%)
 
Weekly Expected Move ±79.2%
$-1 $0 $2 $4 $5
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · $1.2M mcap · 186535 float · 1073.05% daily turnover · Short 53% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$54M +10.7% ▲
5Y CAGR: +42.9%
Gross Profit
$8M -14.2% ▼
5Y CAGR: +16.6%
Operating Income
-$10M +20.0% ▲
Net Income
-$11M -11.4% ▼
EPS (Diluted)
$-4.51 -1.3% ▼
EBITDA
-$6M -120.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$16M$34M$54M$49M$54M
YoY Growth+75.1%+114.3%+59.6%-10.2%+10.7%
Cost of Revenue$5M$28M$45M$39M$46M
Gross Profit$10M$6M$9M$10M$8M
Gross Margin65.9%18.6%16.9%20.2%15.6%
R&D Expenses$136K$0$0$0$0
SG&A Expenses$19M$28M$29M$19M$13M
Operating Expenses$19M$29M$40M$23M$19M
Operating Income-$8M-$23M-$31M-$13M-$10M
Operating Margin-51.9%-67.6%-56.7%-26.2%-18.9%
Interest Expense$21M$673K$2M$4M$4M
Income Before Tax-$28M-$164K-$26M-$9M-$13M
Tax Expense$262K$500K-$1M$771K-$1M
Net Income-$29M-$18M-$189M-$9M-$11M
Net Margin-180.6%-52.2%-347.6%-19.5%-19.6%
EPS (Diluted)$-7.45$-3.00$-161.88$-4.45$-4.51
EBITDA-$7M$6M-$17M-$3M-$6M
Shares Outstanding4M6M1M2M2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms